Health Condition 1: null- Stage I HYPERTENSION
Conditions
Interventions
Intervention1: Evolvulus alsinoides: Hydro-alcoholic Extract of 8 g powder filled in capsules once daily for 6 Weeks
Control Intervention1: Ramipril: 5 mg once daily for 6 Weeks
Sponsors
Jamia Hamdard
DEPARTMENT OF MOALAJAT
Eligibility
Inclusion criteria
Inclusion criteria: Patients with essential hypertension (stage I hypertension based on JNC-7 classification) preferably patients with systolic 140 -155 and diastolic 90-95 mm Hg Clinically stable patients Patients of both genders Patients not taking any anti-hypertensive drugs Patients willing to sign the informed consent form and participate in the trial voluntarily
Exclusion criteria
Exclusion criteria: Stage II essential hypertension Secondary hypertension Diabetes mellitus and thyroid dysfunctions Patients with acute infectious disease/s Patients with systemic disorders like chronic liver, kidney or heart disease etc Pregnant and lactating mothers Terminally ill patients with infectious diseases like AIDS and Tuberculosis etc Patients who fail to give consent Patients who fail to follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure reading Diastolic Blood Pressure reading IL-6 hs-CRPTimepoint: DAY ZERO, 21st DAY, 42nd DAY | — |
Secondary
| Measure | Time frame |
|---|---|
| SIGN AND SYMPTOMS CBC WITH ESR LFT KFT LIPID PROFILE TSH BS F &PP URINE R/M ECG X RAY CHEST USG W/ATimepoint: DAY ZERO, 21ST DAY, 42ND DAY | — |
Countries
India
Contacts
Public ContactDr Umar Jahangir
Jamia Hamdard University
Outcome results
None listed